Drug Shortage Report for TRAVASOL
| Report ID | 146106 |
| Drug Identification Number | 00872296 |
| Brand name | TRAVASOL |
| Common or Proper name | Amino Acids (Blend C) Injection |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | LEUCINE SERINE TYROSINE PROLINE ARGININE GLYCINE L-ALANINE TRYPTOPHAN THREONINE HISTIDINE VALINE ISOLEUCINE L-LYSINE METHIONINE PHENYLALANINE |
| Strength(s) | 730MG 500MG 40MG 680MG 1.15G 1.03G 2.07G 180MG 420MG 480MG 580MG 600MG 580MG 400MG 560MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1000 mL (JB6584) |
| ATC code | B05BA |
| ATC description | I.V. SOLUTIONS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2021-09-23 |
| Estimated end date | 2021-10-01 |
| Actual end date | 2021-10-01 |
| Shortage status | Resolved |
| Updated date | 2021-10-02 |
| Company comments | Baxter is experiencing supply constraints due to the shortage of Travasol 10% 3000mL (DIN 00872296). As a result this product has been placed on allocation at 100% of historical usage. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2021-10-02 | English | Compare |
| v5 | 2021-10-01 | French | Compare |
| v4 | 2021-10-01 | English | Compare |
| v3 | 2021-09-24 | English | Compare |
| v2 | 2021-09-23 | French | Compare |
| v1 | 2021-09-23 | English | Compare |
Showing 1 to 6 of 6